• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives Chlorinated biphenyls

Introduction to 2-chloro-4-(4-pyrrolidin-1-ylsulfonylphenyl)benzoic Acid (CAS No. 1261972-11-5) and Its Emerging Applications in Chemical Biology

2-chloro-4-(4-pyrrolidin-1-ylsulfonylphenyl)benzoic acid, identified by the Chemical Abstracts Service Number (CAS No.) 1261972-11-5, is a sophisticated organic compound that has garnered significant attention in the realm of chemical biology and pharmaceutical research. This compound belongs to a class of benzoic acid derivatives characterized by the presence of a chloro substituent and a sulfonylpyrrolidine moiety, which endows it with unique structural and functional properties. The molecular architecture of this compound not only makes it a promising candidate for drug discovery but also opens up avenues for exploring its potential in various biological pathways.

The structural features of 2-chloro-4-(4-pyrrolidin-1-ylsulfonylphenyl)benzoic acid are particularly noteworthy. The benzoic acid core is a well-known pharmacophore that is frequently encountered in medicinal chemistry due to its ability to interact with biological targets. The introduction of a chloro group at the 2-position enhances the lipophilicity of the molecule, while the sulfonylpyrrolidine side chain introduces hydrogen bonding capabilities and additional binding pockets. These modifications make the compound an attractive scaffold for designing molecules with improved bioavailability and target specificity.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting protein-protein interactions (PPIs), which play a crucial role in numerous disease pathways. The sulfonylpyrrolidine moiety in 2-chloro-4-(4-pyrrolidin-1-ylsulfonylphenyl)benzoic acid is particularly relevant in this context, as it has been shown to mimic the structure of natural ligands and disrupt PPIs effectively. This property has led to its investigation as a potential therapeutic agent in conditions such as cancer, inflammation, and neurodegenerative diseases.

One of the most compelling aspects of 2-chloro-4-(4-pyrrolidin-1-ylsulfonylphenyl)benzoic acid is its versatility in drug design. Researchers have leveraged its scaffold to develop derivatives with enhanced pharmacological profiles. For instance, modifications at the 3-position of the benzoic acid ring have been explored to introduce additional functional groups that can modulate receptor binding affinity and selectivity. These efforts have resulted in several novel compounds that exhibit promising preclinical activity against various disease models.

The compound's potential extends beyond traditional pharmacological applications. Recent studies have highlighted its utility as an intermediate in the synthesis of more complex molecules with specialized functions. For example, its ability to serve as a precursor for heterocyclic compounds has opened up new possibilities for designing molecules with unique biological activities. This underscores the importance of 2-chloro-4-(4-pyrrolidin-1-ylsulfonylphenyl)benzoic acid as a building block in synthetic chemistry.

The synthesis of 2-chloro-4-(4-pyrrolidin-1-ylsulfonylphenyl)benzoic acid presents both challenges and opportunities for chemists. The multi-step synthesis involves key transformations such as sulfonylation, condensation, and chlorination, each requiring precise control to achieve high yields and purity. Advances in synthetic methodologies have enabled more efficient routes to this compound, making it more accessible for research purposes. These advancements are crucial for accelerating drug discovery efforts and translating laboratory findings into clinical applications.

From a computational chemistry perspective, 2-chloro-4-(4-pyrrolidin-1-ylsulfonylphenyl)benzoic acid has been extensively studied using molecular modeling techniques. These studies have provided insights into its binding mode with biological targets, helping researchers optimize its structure for improved efficacy. The integration of computational methods with experimental data has been instrumental in understanding the compound's mechanism of action and identifying potential lead compounds for further development.

The safety profile of 2-chloro-4-(4-pyrrolidin-1-ylsulfonylphenyl)benzoic acid is another critical aspect that has been evaluated through rigorous toxicological studies. Preliminary data suggest that the compound exhibits moderate solubility in water and organic solvents, which influences its formulation and delivery systems. Additionally, its metabolic stability has been assessed to ensure that it behaves predictably within biological systems. These findings are essential for guiding dosing regimens and minimizing potential side effects in future clinical trials.

The future prospects for 2-chloro-4-(4-pyrrolidin-1-ylsulfonylphenyl)benzoic acid are bright, with ongoing research exploring its potential applications in areas such as targeted therapy and personalized medicine. The compound's unique structural features make it an excellent candidate for developing next-generation therapeutics that can address unmet medical needs. As our understanding of biological pathways continues to evolve, so too will our ability to harness the full therapeutic potential of this remarkable molecule.

• 109029-95-0(2-Chloro-5-(piperidine-1-sulfonyl)benzoic Acid)
• 38583-82-3(Benzoic acid, 2-chloro-5-[(4-chloro-1-piperidinyl)sulfonyl]-)
• 37117-01-4(Benzoic acid, 2-chloro-5-[(octahydro-1H-azonin-1-yl)sulfonyl]-)
• 37087-95-9(Benzoic acid, 2-chloro-4-[(3,5-dimethyl-1-piperidinyl)sulfonyl]-, cis-)
• 351336-24-8(2,4-dichloro-5-(pyrrolidine-1-sulfonyl)benzoic acid)
• 53552-96-8(Benzoic acid, 2,3-dichloro-5-(1-piperidinylsulfonyl)-)
• 53552-97-9(Benzoic acid, 2,3-dichloro-5-[(dibutylamino)sulfonyl]-)
• 151104-21-1(2-Chloro-5-(pyrrolidine-1-sulfonyl)benzoic Acid)
• 1261916-25-9(2-chloro-4-(3-pyrrolidin-1-ylsulfonylphenyl)benzoic Acid)
• 1261982-09-5(2-chloro-4-(4-piperidin-1-ylsulfonylphenyl)benzoic Acid)